Panretin oral is in several advanced trials including Kaposi Sarcoma, Acute Promyelocytic Leukemia, and psoriasis (I believe that the psoriasis Phase II trial has been completed).
For the gel, LGND has talked about squamous cell carcinomas, but to my knowledge, such trials have not begun. Applications for non-malignant conditions such as acne, psoriasis, and wrinkles are easy to envision, because Pantein's (9-cis retinoic acid) molecular cousins, Tretinoin (all-trans retinoic acid) and isotretinoin (13-cis retinoic acid) are the active ingredients in approved topical treatments such as Retin-A, Renova, and Accutane. However, to my knowledge, LGND has not begun clinical treatments in these areas. |
